Evaluation of the Effects of Undenatured Type II Collagen (UC-II) as Compared to Robenacoxib on the Mobility Impairment Induced by Osteoarthritis in Dogs.
chronic disease
management of pain
multimodal analgesia
osteoarthritis in dogs
Journal
Veterinary sciences
ISSN: 2306-7381
Titre abrégé: Vet Sci
Pays: Switzerland
ID NLM: 101680127
Informations de publication
Date de publication:
04 Sep 2019
04 Sep 2019
Historique:
received:
15
07
2019
revised:
27
08
2019
accepted:
29
08
2019
entrez:
7
9
2019
pubmed:
7
9
2019
medline:
7
9
2019
Statut:
epublish
Résumé
Osteoarthritis (OA) is a chronic disease that requires a multimodal therapeutic approach. The aim of this study was to evaluate the effects of undenatured type II collagen (UC-II) as compared to robenacoxib in dogs affected by OA. Our hypothesis was that the two compounds would be similar (non-inferiority) in improving mobility. To test this hypothesis, a complete orthopedic examination, x-ray and the Liverpool Osteoarthritis in Dogs (LOAD) survey were performed in dogs affected by OA before and after the treatments. The study was designed as a clinical, randomized, controlled and prospective study. Sixty client-owned dogs were randomized in the R group (
Identifiants
pubmed: 31487772
pii: vetsci6030072
doi: 10.3390/vetsci6030072
pmc: PMC6789547
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J S Afr Vet Assoc. 1997 Mar;68(1):21-5
pubmed: 9186936
Toxicol Mech Methods. 2007;17(4):189-96
pubmed: 20020968
Curr Opin Rheumatol. 2008 Sep;20(5):565-72
pubmed: 18698179
BMC Vet Res. 2013 Mar 01;9:42
pubmed: 23452411
Vet Ther. 2005 Fall;6(3):237-51
pubmed: 16299670
J Vet Intern Med. 2013 Sep-Oct;27(5):1011-9
pubmed: 23782347
J Am Vet Med Assoc. 2005 Oct 1;227(7):1112-7
pubmed: 16220672
Nat Rev Rheumatol. 2016 Oct;12(10):580-92
pubmed: 27539668
Acta Vet Scand. 2005;46(1-2):57-68
pubmed: 16108213
Stat Med. 2004 Jun 30;23(12):1921-86
pubmed: 15195324
Vet Clin North Am Small Anim Pract. 1997 Jul;27(4):883-911
pubmed: 9243786
Vet J. 2018 May;235:1-8
pubmed: 29704933
Int J Med Sci. 2009 Oct 09;6(6):312-21
pubmed: 19847319
J Vet Pharmacol Ther. 2011 Jun;34(3):298-311
pubmed: 21492194
J Vet Pharmacol Ther. 2012 Apr;35(2):175-83
pubmed: 21480932
Res Vet Sci. 2013 Oct;95(2):580-7
pubmed: 23726662
Am J Vet Res. 2007 Mar;68(3):258-64
pubmed: 17331014
Vet Anaesth Analg. 2017 Nov;44(6):1373-1381
pubmed: 29167071
Ther Adv Musculoskelet Dis. 2013 Apr;5(2):77-94
pubmed: 23641259
Vet Clin North Am Small Anim Pract. 2008 Nov;38(6):1449-70, viii
pubmed: 18954692
J Vet Pharmacol Ther. 2010 Apr;33(2):118-31
pubmed: 20444036
PLoS One. 2013;8(3):e58125
pubmed: 23505459
Nat Rev Rheumatol. 2015 Jan;11(1):35-44
pubmed: 25266449
J Vet Intern Med. 2016 May;30(3):836-46
pubmed: 26971876
Vet Surg. 2012 Jul;41(5):545-50
pubmed: 22731937
J Am Vet Med Assoc. 2012 Nov 15;241(10):1314-9
pubmed: 23113523
J Anim Physiol Anim Nutr (Berl). 2012 Oct;96(5):770-7
pubmed: 21623931
Pharm Res. 2010 Dec;27(12):2633-45
pubmed: 20922466
Res Vet Sci. 2010 Jun;88(3):497-506
pubmed: 20004922
Rheum Dis Clin North Am. 1998 Aug;24(3):525-36
pubmed: 9710885
BMC Vet Res. 2018 Aug 17;14(1):242
pubmed: 30119677
Mod Rheumatol. 2009;19(6):581-9
pubmed: 19697097
J Vet Pharmacol Ther. 2009 Dec;32(6):577-84
pubmed: 20444013